418 related articles for article (PubMed ID: 10612667)
1. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
[TBL] [Abstract][Full Text] [Related]
2. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
3. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
[TBL] [Abstract][Full Text] [Related]
4. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
[TBL] [Abstract][Full Text] [Related]
5. Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages.
Zheng YH; Sentsui H; Kono Y; Ikuta K
Virus Res; 2000 Jun; 68(1):93-8. PubMed ID: 10930666
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
[TBL] [Abstract][Full Text] [Related]
7. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the long terminal repeat from a cytopathic strain of equine infectious anemia virus.
Madden CR; Shih DS
Virology; 1996 Nov; 225(2):395-9. PubMed ID: 8918926
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.
Maury W; Thompson RJ; Jones Q; Bradley S; Denke T; Baccam P; Smazik M; Oaks JL
J Virol; 2005 May; 79(9):5653-64. PubMed ID: 15827180
[TBL] [Abstract][Full Text] [Related]
10. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y
Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485
[TBL] [Abstract][Full Text] [Related]
11. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies
Wang XF; Liu Q; Wang YH; Wang S; Chen J; Lin YZ; Ma J; Zhou JH; Wang X
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386282
[TBL] [Abstract][Full Text] [Related]
13. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
Maury WJ; Carpenter S; Graves K; Chesebro B
Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
[TBL] [Abstract][Full Text] [Related]
14. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.
Liang H; He X; Shen RX; Shen T; Tong X; Ma Y; Xiang WH; Zhang XY; Shao YM
Arch Virol; 2006 Jul; 151(7):1387-403. PubMed ID: 16502285
[TBL] [Abstract][Full Text] [Related]
15. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.
Maury W; Bradley S; Wright B; Hines R
Virology; 2000 Feb; 267(2):267-78. PubMed ID: 10662622
[TBL] [Abstract][Full Text] [Related]
16. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
[TBL] [Abstract][Full Text] [Related]
17. Phorbol ester stimulation of equine macrophage cultures alters expression of equine infectious anemia virus.
Sellon DC; Walker KM; Russell KE; Perry ST; Fuller FJ
Vet Microbiol; 1996 Oct; 52(3-4):209-21. PubMed ID: 8972047
[TBL] [Abstract][Full Text] [Related]
18. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
[TBL] [Abstract][Full Text] [Related]
19. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.
Maury W; Perryman S; Oaks JL; Seid BK; Crawford T; McGuire T; Carpenter S
J Virol; 1997 Jul; 71(7):4929-37. PubMed ID: 9188555
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages.
Steagall WK; Robek MD; Perry ST; Fuller FJ; Payne SL
Virology; 1995 Jul; 210(2):302-13. PubMed ID: 7542416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
